Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Baxter International Inc. or Insulet Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Baxter International Inc. and Insulet Corporation compare based on key financial metrics to determine which better meets your investment needs.

About Baxter International Inc. and Insulet Corporation

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Latest Health Care Equipment & Supplies and Baxter International Inc., Insulet Corporation Stock News

As of September 11, 2026, Baxter International Inc. had a $12.3 billion market capitalization, compared to the Health Care Equipment & Supplies median of $385.8 million. Baxter International Inc.’s stock is up 24.5% in 2026, down 6.9% in the previous five trading days and down 0.75% in the past year.

Currently, Baxter International Inc. does not have a price-earnings ratio. Baxter International Inc.’s trailing 12-month revenue is $11.5 billion with a -9.3% net profit margin. Year-over-year quarterly sales growth most recently was 5.3%. Analysts expect adjusted earnings to reach $2.047 per share for the current fiscal year. Baxter International Inc. currently has a 0.2% dividend yield.

As of September 11, 2026, Insulet Corporation had a $9.2 billion market cap, putting it in the 76th percentile of all stocks. Insulet Corporation’s stock is down 53.6% in 2026, down 12.4% in the previous five trading days and down 60.91% in the past year.

Currently, Insulet Corporation’s price-earnings ratio is 24.9. Insulet Corporation’s trailing 12-month revenue is $3.1 billion with a 12.3% net profit margin. Year-over-year quarterly sales growth most recently was 23.5%. Analysts expect adjusted earnings to reach $6.503 per share for the current fiscal year. Insulet Corporation does not currently pay a dividend.

How We Compare Baxter International Inc. and Insulet Corporation Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Baxter International Inc. and Insulet Corporation’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Baxter International Inc. and Insulet Corporation Stock Value Grades

Company	Ticker	Value
Baxter International Inc.	BAX	C
Insulet Corporation	PODD	D

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Baxter International Inc. has a Value Score of 51, which is Average. Insulet Corporation has a Value Score of 22, which is Expensive.

The Value Stock Winner: No Clear Winner

Neither Baxter International Inc. or Insulet Corporation has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Baxter International Inc. or Insulet Corporation is the better investment when it comes to value.

Baxter International Inc. and Insulet Corporation’s Quality Grades

Company	Ticker	Quality
Baxter International Inc.	BAX	C
Insulet Corporation	PODD	A

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Baxter International Inc. has a Quality Score of 58, which is Average. Insulet Corporation has a Quality Score of 99, which is Very Strong.

The Quality Grade Winner: Insulet Corporation

As you can clearly see from the Quality Grade breakdown above, Insulet Corporation has a better overall quality grade than Baxter International Inc.. For investors who are looking for companies with higher quality than others in the same industry, Insulet Corporation could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Baxter International Inc. and Insulet Corporation’s Momentum Grades

Company	Ticker	Momentum
Baxter International Inc.	BAX	C
Insulet Corporation	PODD	F

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Baxter International Inc. has a Momentum Score of 55, which is Average. Insulet Corporation has a Momentum Score of 11, which is Very Weak.

The Momentum Stock Winner: No Clear Winner

Neither Baxter International Inc. or Insulet Corporation has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Baxter International Inc. or Insulet Corporation is the better investment when it comes to momentum.

Other Baxter International Inc. and Insulet Corporation Grades

In addition to Momentum, Quality and Value, A+ Investor also provides grades for Growth and Estimate Revisions.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Baxter International Inc. and Insulet Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Baxter International Inc. or Insulet Corporation Stock?

Overall, Baxter International Inc. stock has a Value Score of 51, Momentum Score of 55 and Quality Score of 58.

Insulet Corporation stock has a Value Score of 22, Momentum Score of 11 and Quality Score of 99.

Comparing Baxter International Inc. and Insulet Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.